Original Article

Evaluation of Renal Function Estimation Formulas Specific to Dynamic Renal Function for Drug Dosing in Critically Ill Patients

Authors: Lianjie Xiong, PharmD, MS, Z. Kevin Lu, PhD, April Miller Quidley, PharmD, Bebbyn S. Alford, PharmD, P. Brandon Bookstaver, PharmD

Abstract

Objectives: The study compared estimated creatinine clearance (eCrCl) between the Cockcroft-Gault (CG) equation and the Jelliffe, Chiou, and Brater equations designed for estimation in dynamic renal function and resulting antimicrobial dosing concordance of five antimicrobials (cefepime, meropenem, piperacillin/tazobactam, vancomycin, and fluconazole) commonly used in the intensive care unit (ICU).

Methods: Electronic medical records were used to identify the target patient population. Analysis of variance tests with repeated measures were performed to compare eCrCl. Bowker’s tests of symmetry were applied to compare the dosing regimen discordance between CG and candidate equations.

Results: From January 1, 2008 through December 31, 2012, we identified 387 patients with acute kidney injury (AKI), among whom 62% (n = 240) were older adults (65 years and older) and 46% (n = 178) were obese (body mass index ≥30). In the declining phase of renal function, eCrCl means were different between the CG and Brater equations (32.0 vs 26.1 mL/min, P < 0.001). The dosing regimen discordance rates (CG vs candidate equations) in declining renal function varied from 19.3% to 25% and were statistically significant for cefepime and meropenem (P < 0.001) based on Food and Drug Administration recommendations for dose adjustment. In the improving phase, eCrCl means were different (P < 0.001) between CG (43.0 mL/min) and candidate formulas (Brater 47.9, Chiou 31.7, and Jelliffe 55.3 mL/min). The dosing regimen discordance rates (CG vs candidate equations) in the improving phase varied from 8.3% to 39% and were statistically significant for all 5 antimicrobials (P < 0.001).

Conclusions: Differences in eCrCl between CG and candidate formulas were observed in surgical ICU patients with acute kidney injury. Discordant dosing recommendations may affect antimicrobial regimens in ICU patients with dynamic renal function.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009;35:1692-1702.
 
2. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483.
 
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
 
4. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. https://www.kidney.org/sites/default/files/docs/ckd_evaluation_classification_stratification.pdf. Published 2002. Accessed January 1, 2015.
 
5. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
 
6. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
 
7. National Institute of Diabetes and Digestive and Kidney Diseases. CKD and drug dosing: information for providers. Estimation of kidney function for prescription medication dosage in adults. https://www.niddk.nih.gov/health-information/health-communication-programs/nkdep/a-z/ckd-drug-dosing/Pages/CKD-drug-dosing.aspx. Accessed August 9, 2017.
 
8. Nyman HA, Dowling TC, Hudson JQ, et al. Comparative evaluation of the Cockcroft-Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31:1130-1144.
 
9. Ijo I, Feyerharm J. Pharmacy intervention on antimicrobial management of critically ill patients. Pharm Pract (Granada) 2011;9:106-109.
 
10. Jelliffe RW, Jelliffe SM. A computer program for estimation of creatinine clearance from unstable serum creatinine concentration. Math Biosci 1972;14:17-24.
 
11. Chiou WL, Hsu FH. A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogenous creatinine. Res Comm Chem Pathol Pharmacol 1975;10:315-330.
 
12. Brater DC. Drug Use in Renal Disease. Balgowlah, Australia: ADIS Health Science Press; 1983:22-56.
 
13. Quidley AM, Bookstaver PB. 122: Comparison of traditional methods for renal function estimation with methods designed for estimation in acute kidney injury (AKI) and the potential impact on antimicrobial dosing. Crit Care Med 2012;40:1-328.
 
14. Cefepime [package insert]. Schaumburg, IL: Sagent; 2012.
15. Fluconazole  [package insert]. Deerfield, IL: Baxter; 2010.
16. Meropenem [package insert]. Schaumburg, IL: APP; 2011
17. Zosyn (piperacillin and tazobactam)  [package insert]. Philadelphia: Wyeth; 2009.
18. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98.
 
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
 
20. Roberts JA, Norris R, Paterson DL, et al. Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol 2012;73:27-36.
 
21. Lamoth F, Buclin T, Pascual A, et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother 2010;54:4360-4367.
 
22. Miller AD, Ball AM, Bookstaver PB, et al. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy 2011;31:408-423.
 
23. Hammond DA, Smith MN, Li C, et al. Systematic review and meta-analysis of acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam. Clin Infect Dis 2017;64:666-674.
 
24. Molnar AO, van Walraven C, McArthur E, et al. Validation of administrative database codes for acute kidney injury in kidney transplant recipients. Can J Kidney Health Dis 2016;7:18.